Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs

Neuroscience Letters

Volumn 436, Issue 2, 2008, Pages 239-244

  Wilkinson, Kevin A ^a   Nishimune, Atsushi ^a   Henley, Jeremy M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

GluR7; Group III mGluRs; Kainate receptor; Metabotropic glutamate receptors; Posttranslational modification; SUMO; SUMOylation; Synaptic protein

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 7; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 3; NERVE PROTEIN; SUMO 1 PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN MOTIF; RNA TRANSLATION; SYNAPTIC POTENTIAL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CONSENSUS SEQUENCE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUMO-1 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 41949097511     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.03.029     Document Type: Article

References (37)

1. Bayer P., Arndt A., Metzger S., Mahajan R., Melchior F., Jaenicke R., and Becker J. Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280 (1998) 275-286
2. Bohren K.M., Nadkarni V., Song J.H., Gabbay K.H., and Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279 (2004) 27233-27238
3. Carlton J.G., and Cullen P.J. Sorting nexins. Curr. Biol. 15 (2005) R819-R820
4. Cimarosti H., Lindberg C., Bomholt S.F., Rønn L.C.B., and Henley J.M. Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology 54 (2008) 280-289
5. Denison C., Rudner A.D., Gerber S.A., Bakalarski C.E., Moazed D., and Gygi S.P. A proteomic strategy for gaining insights into protein sumoylation in yeast. Mol. Cell Proteomics 4 (2005) 246-254
6. Desterro J.M., Rodriguez M.S., Kemp G.D., and Hay R.T. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274 (1999) 10618-10624
7. Dev K.K. PDZ domain protein-protein interactions: a case study with PICK1. Curr. Top. Med. Chem. 7 (2007) 3-20
8. Enz R. The trick of the tail: protein-protein interactions of metabotropic glutamate receptors. Bioessays 29 (2007) 60-73
9. Ganesan A.K., Kho Y., Kim S.C., Chen Y., Zhao Y., and White M.A. Broad spectrum identification of SUMO substrates in melanoma cells. Proteomics 7 (2007) 2216-2221
10. Geiss-Friedlander R., and Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8 (2007) 947-956
11. Gocke C.B., Yu H., and Kang J. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 280 (2005) 5004-5012
12. Gomperts S.N. Clustering membrane proteins: it's all coming together with the PSD-95/SAP90 protein family. Cell 84 (1996) 659-662
13. Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J., Nakai A., and Sistonen L. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. USA 103 (2006) 45-50
14. Hirbec H., Martin S., and Henley J.M. Syntenin is involved in the developmental regulation of neuronal membrane architecture. Mol. Cell Neurosci. 28 (2005) 737-746
15. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 73 (2004) 355-382
16. Kantamneni S., Correa S.A., Hodgkinson G.K., Meyer G., Vinh N.N., Henley J.M., and Nishimune A. GISP: a novel brain-specific protein that promotes surface expression and function of GABA(B) receptors. J. Neurochem. 100 (2007) 1003-1017
17. Lapenta V., Chiurazzi P., van der Spek P., Pizzuti A., Hanaoka F., and Brahe C. SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. Genomics 40 (1997) 362-366
18. Lee S.H., Liu L., Wang Y.T., and Sheng M. Clathrin adaptor AP2 and NSF interact with overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and hippocampal LTD. Neuron 36 (2002) 661-674
19. Lee Y.J., Miyake S., Wakita H., McMullen D.C., Azuma Y., Auh S., and Hallenbeck J.M. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J. Cereb Blood Flow Metab. 27 (2007) 950-962
20. Martin S., Nishimune A., Mellor J.R., and Henley J.M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447 (2007) 321-325
21. Martin S., Wilkinson K.A., Nishimune A., and Henley J.M. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8 (2007) 948-959
22. Matunis M.J., Coutavas E., and Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135 (1996) 1457-1470
23. Okuma T., Honda R., Ichikawa G., Tsumagari N., and Yasuda H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254 (1999) 693-698
24. Owerbach D., McKay E.M., Yeh E.T., Gabbay K.H., and Bohren K.M. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem. Biophys. Res. Commun. 337 (2005) 517-520
25. Palmer C.L., Cotton L., and Henley J.M. The molecular pharmacology and cell biology of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol. Rev. 57 (2005) 253-277
26. Rizo J., Chen X., and Arac D. Unraveling the mechanisms of synaptotagmin and SNARE function in neurotransmitter release. Trends Cell Biol. 16 (2006) 339-350
27. Rodriguez M.S., Desterro J.M., Lain S., Midgley C.A., Lane D.P., and Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18 (1999) 6455-6461
28. Rosas-Acosta G., Langereis M.A., Deyrieux A., and Wilson V.G. Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331 (2005) 190-203
29. Sampson D.A., Wang M., and Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276 (2001) 21664-21669
30. Stenbeck G. Soluble NSF-attachment proteins. Int. J. Biochem. Cell Biol. 30 (1998) 573-577
31. Sternsdorf T., Jensen K., and Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139 (1997) 1621-1634
32. Tang Z., El Far O., Betz H., and Scheschonka A. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. J. Biol. Chem. 280 (2005) 38153-38159
33. Uchimura Y., Nakamura M., Sugasawa K., Nakao M., and Saitoh H. Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli. Anal. Biochem. 331 (2004) 204-206
34. Uchimura Y., Nakao M., and Saitoh H. Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway. FEBS Lett. 564 (2004) 85-90
35. Wykoff D.D., and O'Shea E.K. Identification of sumoylated proteins by systematic immunoprecipitation of the budding yeast proteome. Mol. Cell Proteomics 4 (2005) 73-83
36. Yang S.H., Galanis A., Witty J., and Sharrocks A.D. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25 (2006) 5083-5093
37. Yang W., Sheng H., Warner D.S., and Paschen W. Transient global cerebral ischemia induces a massive increase in protein sumoylation. J. Cereb Blood Flow Metab. (2007) 1-11